Alpha Centric Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Alpha Centric Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$62.39 - $113.8 $308,081 - $561,944	-4,938 Reduced 16.22%	25,500 $2.9 Million
Q3 2022 Nov 08, 2022	BUY	$58.92 - $84.67 $1.72 Million - $2.47 Million	29,118 Added 2205.91%	30,438 $1.88 Million
Q4 2021 Feb 25, 2022	BUY	$98.56 - $119.91 $31,539 - $38,371	320 Added 32.0%	1,320 $142,000
Q4 2020 Mar 11, 2022	BUY	$67.0 - $84.39 $28,475 - $35,865	425 Added 73.91%	1,000 $73,000
Q3 2020 Mar 11, 2022	SELL	$55.23 - $79.93 $8,284 - $11,989	-150 Reduced 20.69%	575 $45,000

Q2 2020 Mar 11, 2022	BUY	$30.2 - $56.98 $21,895 - $41,310	725 New	725 $40,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.